The invention generally relates to electrode arrays and, more particularly, the invention relates to implantable neural electrodes for neurostimulation devices.
Electrical stimulation therapy commonly uses a number of modalities, such implantable arrays having electrodes connected with physiological neural tissue. To that end, during use, an implanted pulse generator directs prescribed signals to the electrodes for a desired therapeutic result. In addition, the generator may record neural information from the tissue to inform therapy delivery. When used for chronic pain in the spinal cord, for example, the implantable array often has a large number of electrical electrodes to enable spatially selective therapy to targeted volumes of neural tissue. This technique commonly provides effective pain relief therapy to specific full or partial dermatomes (e.g., an extremity such as the foot, leg, lower back, hand, etc.).
Those in the art often use multi-contact electrodes to deliver energy to small tissue volumes adjacent to each contact spaced 1) laterally across the spinal cord and 2) longitudinally at one or more vertebral levels. In other anatomies such as the retina, arrays of high-density electrodes enable finer spatial stimulation to improve the resolution of vision. In cortical anatomies, high-density electrodes can be used to focus stimulation to target volumes to provide therapy and eliminate stimulating unwanted areas known to cause off-target effects (loss of speech or memory). In spinal cord anatomies, high-density electrodes can be used to provide therapeutic access to numerous dermatomes where pain is experienced, which may be at different vertebral levels, nerve roots, or distinct positions across the spinal cord.
Undesirably, prior art arrays often suffer from robustness issues, which can cause them to break apart within a patient's body. This can cause the need for immediate medical treatment, potentially harming the patient.
In accordance with one embodiment of the invention, an electrode array system includes a unitary body forming a plurality of apertures, and a plurality of continuous conductive elements (e.g., a metal layer) at least partially encapsulated within the unitary body. The continuous conductive elements include/form a plurality of contacts, a plurality of electrode sites configured to couple with a neural tissue (e.g., the spinal nerve or a peripheral nerve), and a plurality of interconnects extending between the plurality of contacts and the plurality of electrode sites. The plurality of electrode sites are aligned with the plurality of apertures, and the plurality of apertures expose the plurality of electrode sites.
As a unitary design, the body preferably is seamless. Moreover, each contact may connect with at least one electrode by at least one interconnect.
The unitary body may be formed a material having a body tensile strength, while the electrode array system further includes a reinforcing material at least partly encapsulated by the unitary body. The reinforcing material may have a reinforcing tensile strength that is greater than the body tensile strength. Among other things, the reinforcing material may include a woven or braided structure and/or one in which multiple fibers are oriented in multiple directions. In a similar manner, the reinforcing material may include a polymer, nano or micro-particles or fibers, a hybrid or composite material, or other material with appropriate material properties. For example, the unitary body may be formed from vulcanized silicone, polyurethane, or other cured, dried, or set polymers.
The unitary body can be considered to have a top surface that forms the plurality of apertures. The plurality of electrode sites thus may be recessed below the top surface. Furthermore, the continuous conductive elements may be formed from a thin film or a foil.
The system may include a lead coupled with the plurality of contacts. This lead has a proximal contact array (at a generator port) configured to couple with a pulse generator. Accordingly, the system also may include a pulse generator having a lead port to which the contact array of the generator port couples.
In accordance with another embodiment of the invention, a method of fabricating an electrode array forms a first unvulcanized layer and a second unvulcanized layer, and patterns a conductive layer to produce a plurality of continuous conductive elements to form a plurality of contacts, a plurality of electrode sites, and a plurality of interconnects extending between the plurality of contacts and the plurality of electrode sites. The method further forms apertures in at least one of the first and second unvulcanized layers, couples the continuous conductive elements with one of the first and second unvulcanized layers, and couples together the first and second unvulcanized layers in a manner that at least partially encapsulates the continuous conductive elements. Next, the method vulcanizes the unvulcanized layers after coupling them together to form a flexible vulcanized unitary body. The plurality of apertures of the vulcanized unitary body expose the plurality of electrode sites.
Some embodiments form multiple layers of continuous conductive elements and form the unitary body from more than two unvulcanized layers.
Those skilled in the art should more fully appreciate advantages of various embodiments of the invention from the following “Description of Illustrative Embodiments,” discussed with reference to the drawings summarized immediately below.
6B, and 6C schematically show cross-sectional views of a fusion bond substrate configured in accordance with illustrative embodiments of the invention.
In illustrative embodiments, an implantable electrode array has a robust construction that should more readily withstand expected forces within the human body. To that end, the implantable electrode array has a substantially unitary, fused body that encapsulates an internal metal layer. Having a unitary body eliminates weak bonding points, minimizing the likelihood that portions of the electrode array delaminate from one another. Details of illustrative embodiments are discussed below.
Active implantable systems provide therapy for a wide range of neurological, motor deficit, and cardiac diseases. For example, neurostimulator devices include spinal cord stimulation for the treatment of chronic pain, peripheral nerve stimulation for treatment of chronic pain, deep brain stimulation for depression or Parkinson's, and vagus nerve stimulation for epilepsy.
In spinal cord stimulation, an implantable pulse generator generates therapeutic pulses or waveforms for delivery through a therapy array/electrode array 10.
The multi-contact array 10 has many electrode sites 18 exposed to the tissue, efficiently providing multiple points of electrical connection with the spinal cord 16 (including root entry zone, and roots). When electrical stimulation is applied through therapy electrode sites/electrode sites 18 to neural tissue (e.g., to spinal cord 16, peripheral nerves, ganglia, subthalamic nucleus, other brain tissue, or other neural tissue) and other biological tissue (e.g., cardiac, muscle, etc.), low-volume and precision technologies create multi-contact therapy arrays 10. Specifically, multi-contact arrays 10 improve therapy by selectively stimulating partial or sub-volumes of the neural tissue—by distributing stimulation energy (via cathodes and anodes) across one or more electrode sites 18 in proximity with the neural structure. In one embodiment, the multi-contact electrodes enable therapy to be precisely delivered to a sub-volume of the neural target (e.g., specific columns of the spinal dorsal column, particular dorsal root entry zone, dorsal root ganglia, one or more fascicles within a peripheral nerve, ganglia, etc.).
Conventional implantable multi-contact electrode arrays known to the inventors are assembled from non-continuous conductive elements (discrete metal contacts, discrete wires, etc). After the non-continuous conductive elements are connected (e.g., using welding, swaging, or crimping) and placed in a fixture, injection molding techniques position the conductive elements within an insulating elastomer. Conventional approaches, however, undesirably do not scale to ultra-thin (<1 mm), low-profile geometries. In particular, conventional injection molded electrodes assemblies are inherently thick (about 2 mm) due to the bulk volume required for the components and to facilitate the flow of encapsulation during the assembly process. Assembling non-continuous conductive elements and their density limitations of positioning and welding individual contacts and wires also limits these approaches from scaling to more than 16 or 32 electrical contacts.
Micro-fabrication techniques (e.g., photolithography, sputtering, liftoff, and etching) can produce ultra-thin continuous conductive elements (<2 micrometers) on ultra-thin substrates (<20 micrometers). However, thin-film continuous conductive elements are inherently brittle and fracture upon flexure and strain. Under normal handling and mechanical forces encountered within an implanted environment, the thin-conductor may fracture if stretched only up to about 10%. In contrast, elastomer layers used in these applications may stretch 50 percent to 2,000 percent, far exceeding the noted conductive layer limit. The thin-conductors absorb the tensile forces and, frequently, fracture over time.
Further, thin-film polymer substrate materials (e.g., Parylene C, Parylene H, Polyimide, etc.) are unproven in long-term human use electrodes due to their inherent mechanical instability. For example, thin-film polymer substrates suffer from mechanical and electrical instability during long-term aging tests. Specifically, the layers in the substrate are adhesively bonded (in contrast to welding), which fatigues over time, resulting in delamination and loss of insulation between electrodes. Such polymer substrates also have a stiffness approximately 10 times higher than neural tissue, often resulting in neural tissue injury, inflammatory reactions, scar tissue formation around the electrode, and reduction or loss of electrical stimulation therapy due to the encapsulation.
Hybrid elastomer electrodes have also been developed by coating a thin elastomer base substrate, and subsequently 1) attaching a laser-patterned metal conductor layer to the substrate, and 2) coating a thin top elastomer layer, which adhesively bonds to the base substrate. The adhesive bonds used to join the elastomer substrate layers are significantly weaker than the substrate elastomer material (bound together by fusion or welded bonds). The long-term deterioration of the adhesive bonds often leads to delamination between insulating layers in an implanted environment, a loss of isolation and function of the electrode, and eventual loss of therapy. Additionally, thin-conductor materials are fragile under repetitive mechanical stress (stretch, bend, and twisting), causing conductor failure leading to loss of delivery of therapy. To provide resilience to mechanic stress, additional polymer reinforcement material have been added to elastomer substrate stack to balance the mechanical mismatch. Upon stretch, the polymer reinforcement is proportionally strained, thereby preventing the conductors from solely absorbing the strain. However, polymer-elastomer substrates required more complex manufacturing steps, such as the steps of adding the polymer layer and encapsulating the polymer layer to prevent delamination.
In a similar manner, joining the layers using adhesive bonding between dissimilar elastomer and polymer materials produces poor adhesion between layers, which often causes delamination. Specifically, delamination 1) separates insulating materials from each other and the conductive features and 2) causes the electrode to fail to sense signals or deliver stimulus. These undesirable results lead to a loss of therapy.
To affix the conductors in position, the noted substrate layer of prior art hybrid elastomer electrodes is vulcanized. Subsequent steps utilize an additional top layer of elastomer, which is joined using an adhesive bond (the base layer is already cured requiring a wet top layer to adhesively bond). Undesirably, such a continuous adhesive bond between assembled layers produces a weak point—a seam—which often results in long-term delamination at the bond interface (see the seam 44 of
The hybrid elastomer assembly approach has further limitations. For example, application of a continuous wet elastomer contaminates the electrode contacts or conductive contacts. After the substrates are adhesively bonded and vulcanized, the conductive elements are completely encapsulated with no openings or recesses to make electrical connections or to form an electrical connection to tissue. It therefore is then necessary to create openings in the elastomer, and to remove the elastomer that has contaminated the conductive contacts in these areas. An ablative process may serve this purpose (e.g., laser ablation or etching), undesirably exposing ashing residues to the conductive features. In addition to being costly and time-consuming, the residual ashing and debris produced by the ablation process requires extensive cleaning procedures to remove.
Recognizing these problems, the inventors developed an implantable, multi-electrode array 10 without significant weak points (e.g., seams). Instead, the array has a body that is integral/fused—a single continuous structure or body. To that end,
Illustrative embodiments of the electrode array 10 include micro-scale continuous conductive elements, such as electrode sites 18, interconnects 28, conductive contacts 30, and strain relief features 32 that enable high-density implantable therapy arrays 10. The multi-contact electrode array 10 may have a small number of electrodes, or a large number of electrodes (e.g., greater than 16 electrodes) within the noted singular, unitary, fused, ultra-thin substrate 26.
The electrode array 10 includes an electrode site 18 with a conductive surface for delivering electrical stimulation to body tissue. The conductive interconnects 28, within the substrate 26, transmit electrical current from the conductive contacts 30 to the electrode sites 18, which also may provide the interface/bonding sites to the lead 14 (
In accordance with illustrative embodiments and as noted below, a reinforcing material 36 (
Illustrative embodiments form the substrate 26 by fusing at least one discrete upper elastomer layer 34 (referred to as a “cover” or a “cover layer”) and at least one discrete lower elastomer layer 34 (referred to as a “base” or a “base layer”). As discussed below with regard to
The electrode sites 18 and interconnects 28 preferably are formed from a thin, continuous conductor material, such as a substantially flat, thin continuous metal conductor layer (e.g., a metal film or metal foil), with insulating elastomer material 34 on each side of the continuous conductive elements. For additional robustness, the continuous conductive elements may contain anchor features, such as slits, hooks, or holes, enabling insulating elastomer layers 34 to anchor the continuous conductive elements to the elastomer.
To further increase the number of electrode sites 18 and their density, the electrode array substrate 26 also may include more than one layer of continuous conductive elements. For example, the substrate 26 may have two continuous conductive element layers and three elastomer layers, increasing the contact density. In a manner similar to other embodiments, this embodiment also has a unitary, fused substrate 26 and optionally may have a reinforcement material/layer 36 to improve its mechanical properties without increasing its rigidity or appreciable thickness.
In illustrative embodiments, the continuous conductive elements are formed from metal, such as a metal film or a metal sheet (e.g., foil). Other embodiments, however, may form the continuous conductive elements from a conductive polymer, or a hybrid material. Several examples of hybrid materials may include a polymer having internal metal, carbon nanotubes, conductive ink, conductive epoxy, or other conductive materials.
The array 10 may be arranged in any of a variety of different form factors. For example,
6B, and 6C schematically show cross-sectional views of a fusion bonded substrate 26 configured in accordance with illustrative embodiments of the invention.
Additionally, to improve resilience to mechanic stress, illustrative embodiments of
To accomplish its function, the reinforcing material 36 preferably has material properties tuned to those of the unitary body 26. In illustrative embodiments, the reinforcing material 36 has a tensile strength that is greater than that of the unitary body 26. In related embodiments, the reinforcing material 36 has a tear strength that is greater than that of the unitary body 26. Those skilled in the art may configure the body 26 and the reinforcing material 36 to have one or more of these or other relative material properties (e.g., elongation).
As noted above, the electrode array 10 may take on a number of different form factors. For example,
Some embodiments may integrate active or passive electronics into the electrode array 10 (e.g., switching electronics, components making to improve systemic tolerance to magnetic resonant imaging, etc.). To that end,
Indeed, illustrative embodiments may use other form factors not discussed. Accordingly, discussion of specific form factors, such as the noted paddle and cylindrical form factors, are illustrative and not intended to limit additional embodiments.
To help understand
The process of
After the elastomer residuals are removed from the assembly, the assembly forms an unvulcanized, patterned elastomer base layer. The openings 29 and recesses in the elastomer provide a conductive path for the electrical stimulation energy to pass from the electrode sites 18 to the tissue. The openings 29 have rims that are just above the top surfaces of the electrode sites 18. Thus, the electrode sites 18 are slightly recessed relative to the rims of the openings 29.
Optionally, the unvulcanized elastomer substrate 26 may include the noted reinforcing material 36, which also is shown in
Returning to
Next, the process continues to step 1104, which forms the continuous conductive elements. In this example, these elements are formed from a flat/planar layer of metal. In other embodiments, however, other materials may suffice, such as a conductive polymer, a non-flat metal layer, etc. Those skilled in the art thus can apply other materials to form the continuous conductive elements. To those ends,
As shown in
Those skilled in the art may use other spatial patterning technologies, such as film printing, screen printing, deposition or other method(s). Step (c) of
Returning to
Next, step 1110 positions and aligns the metal layer with openings 29 in the cover layer, while step 1112 removes the cover layer carrier substrate 50.
At this point in the process, the base and cover are ready to be fused together to form the single, integral/unitary electrode substrate/body 26 as discussed above. Specifically, step 1114 vulcanizes the assembly to create a permanent elastomer fusion (elastomer-to-elastomer welding), forming the single substrate 26. This involves applying heat and pressure, as required by the materials and application, to fuse the layers together. Among other benefits, the fusion process (v) is expected to provide electrical isolation and implanted electrode longevity. The resulting metal contacts 30 and electrode sites 18 thus are exposed as desired, although they may be recessed slightly below the rims of the openings 29 exposing them.
After completing the process, the fused unitary body 26 may be subjected to various post-processing steps, such as step (vi), which may form the electrode therapy embodiments discussed above (among others) using a curving process to form a curved electrode, cylindrical catheter electrode, nerve-cuff, conformal paddle, or other geometries. The sub-assembly from (v) therefore may be combined with other processes that those skilled in the art may use to form these noted implementations. For example, to form a nerve cuff electrode or a cylindrical catheter style electrode, the substrate 26 can be formed around a mandrel and integrated with other injection molding or centerless grinding steps.
Similarly, the post-processing step (vi) can attach wires from the lead 14 to the contact contacts 30. Among other things, step (iv) can include various types of welding (e.g., thermo compression, resistance welding, laser welding, conductive elastomers, etc.). The welding sites and exposed contact contacts 30 preferably are subsequently molded with thick elastomer insulating encapsulant to provide isolation between the contact contacts 30.
Accordingly, unlike electrode arrays having bodies formed from two or more adhered layers, illustrative embodiments form a unitary single body 26. As a result, the electrode array 10 should be more robust, particularly when subjected to anticipated forces within the human body.
Although the above discussion discloses various exemplary embodiments of the invention, it should be apparent that those skilled in the art can make various modifications that will achieve some of the advantages of the invention without departing from the true scope of the invention.
This patent application is a continuation of U.S. patent application Ser. No. 15/806,005, filed Nov. 7, 2017, entitled, “MULTI-ELECTRODE ARRAY WITH UNITARY BODY,” which claims priority from provisional U.S. patent application No. 62/418,343, filed Nov. 7, 2016, entitled, “MULTI-CHANNEL COUNT ELECTRODE ARRAYS WITH PERFORATED REINFORCEMENT AND PLANAR CONDUCTIVE ELEMENTS,” and naming Bryan McLaughlin as inventor. The disclosures of each of the above-noted patent applications are incorporated herein, in their entireties, by reference.
This invention was made with government support under W911NF-15-C-0007 awarded by US ARMY Contracting Command—Aberdeen (ACC-APG-RTP W911NF). The government has certain rights in the invention.
Number | Name | Date | Kind |
---|---|---|---|
4941961 | Noguchi et al. | Jul 1990 | A |
5417719 | Hull et al. | May 1995 | A |
5689877 | Grill, Jr. et al. | Nov 1997 | A |
6024702 | Versen | Feb 2000 | A |
6871099 | Whitehurst et al. | Mar 2005 | B1 |
7012192 | Stevenson et al. | Mar 2006 | B2 |
7142909 | Greenberg et al. | Nov 2006 | B2 |
7211103 | Greenberg et al. | May 2007 | B2 |
7613524 | Jordan | Nov 2009 | B2 |
7697995 | Cross, Jr. et al. | Apr 2010 | B2 |
7749608 | Laude | Jul 2010 | B2 |
7846285 | Zhou et al. | Dec 2010 | B2 |
7877866 | Greenberg et al. | Feb 2011 | B1 |
8000804 | Wessendorf et al. | Aug 2011 | B1 |
8805542 | Tai et al. | Aug 2014 | B2 |
9002459 | Lee et al. | Apr 2015 | B2 |
9095699 | Rosenberg et al. | Aug 2015 | B2 |
9174038 | Schuttler et al. | Nov 2015 | B2 |
9364660 | Howard et al. | Jun 2016 | B2 |
9387326 | Moffitt | Jul 2016 | B2 |
9409023 | Burdick et al. | Aug 2016 | B2 |
9561363 | Skubitz et al. | Feb 2017 | B2 |
9572976 | Howard et al. | Feb 2017 | B2 |
9656085 | Moffitt et al. | May 2017 | B2 |
11116964 | McLaughlin et al. | Sep 2021 | B2 |
20030233133 | Greenberg et al. | Dec 2003 | A1 |
20060257672 | Horikoshi et al. | Nov 2006 | A1 |
20070207569 | Greenberg et al. | Sep 2007 | A1 |
20110238145 | Swanson | Sep 2011 | A1 |
20110270067 | Faraji et al. | Nov 2011 | A1 |
20110270350 | Feler et al. | Nov 2011 | A1 |
20120006793 | Swanson | Jan 2012 | A1 |
20120245449 | Williams et al. | Sep 2012 | A1 |
20130060313 | Cross, Jr. | Mar 2013 | A1 |
20130345780 | Tabada et al. | Dec 2013 | A1 |
20140039241 | Jarvik | Feb 2014 | A1 |
20140128954 | Schuttler et al. | May 2014 | A1 |
20140172051 | Pannu et al. | Jun 2014 | A1 |
20140180361 | Burdick et al. | Jun 2014 | A1 |
20140180370 | Romero | Jun 2014 | A1 |
20140254124 | Raje et al. | Sep 2014 | A1 |
20160007874 | Ma | Jan 2016 | A1 |
20160158559 | Greenberg et al. | Jun 2016 | A1 |
20160192524 | Ruben | Jun 2016 | A1 |
20160213917 | Dalm et al. | Jul 2016 | A1 |
20160254080 | Shah et al. | Sep 2016 | A1 |
20170120056 | Woods et al. | May 2017 | A1 |
20170157390 | Howard et al. | Jun 2017 | A1 |
20170246452 | Liu et al. | Aug 2017 | A1 |
20180200505 | McLaughlin et al. | Jul 2018 | A1 |
20180213665 | Dittmer et al. | Jul 2018 | A1 |
20200215335 | McLaughlin et al. | Jul 2020 | A1 |
Number | Date | Country |
---|---|---|
2448912 | Jan 2012 | CA |
102783942 | Nov 2012 | CN |
103702714 | Apr 2014 | CN |
103813828 | May 2014 | CN |
104254365 | Dec 2014 | CN |
2007039735 | Apr 2007 | WO |
2017147151 | Aug 2017 | WO |
Entry |
---|
Chinese Patent Office, First Office Action for Chinese Patent Application No. 201780075522.X, dated Nov. 22, 2022, 20 pages. |
**International Search Report—International Application No. PCT/US18/14566 dated Mar. 29, 2018, together with the Written Opinion of the International Searching Authority, 13 pages. |
**International Search Report—International Application No. PCT/US19/68469 dated Mar. 25, 2020, together with the Written Opinion of the International Searching Authority, 11 pages. |
*International Searching Authority, International Search Report—International Application No. PCT/US17/60408, dated Jan. 18, 2018, together with the Written Opinion of the International Searching Authority, 20 pages. |
**Schuettler et al., “Fabrication of implantable microelectrode arrays by laser cutting of silicone rubber and platinum foil*,” http://iopscience.iop.org/article/10.1088/1741-2560/2/1/013/pdf , Journal of Neural Engineering, Institute of Physics Publishing, vol. 2, No. 1, Feb. 22, 2005, pp. S121-S128. |
**Schuettler et al., “Stretchable Tracks for Laser-Machined Neural Electrode Arrays,” 31st Annual International Conference of the IEEE EMBS, Minneapolis, MN, USA, Sep. 2-6, 2009, pp. 1612-1615. |
**Supplementary European Search Report for European Application No. EP 17866496.7, dated Jun. 3, 2020 (9 pages). |
**U.S. Appl. No. 15/876,035, filed Jan. 19, 2018, Spinal Cord Stimulation Method to Treat Lateral Neural Tissues. |
**U.S. Appl. No. 16/680, 171, filed Nov. 11, 2019, Implantable Devices with Welded Multi-Contact Electrodes and Continuous Conductive Elements. |
Number | Date | Country | |
---|---|---|---|
20210402176 A1 | Dec 2021 | US |
Number | Date | Country | |
---|---|---|---|
62418343 | Nov 2016 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15806005 | Nov 2017 | US |
Child | 17473387 | US |